HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer's Disease.

Abstract
Alzheimer's disease (AD) is the most prevalent age-associated neurodegenerative disease. A decrease in autophagy during aging contributes to brain disorders by accumulating potentially toxic substrates in neurons. Rubicon is a well-established inhibitor of autophagy in all cells. However, Rubicon participates in different pathways depending on cell type, and little information is currently available on neuronal Rubicon's role in the AD context. Here, we investigated the cell-specific expression of Rubicon in postmortem brain samples from AD patients and 5xFAD mice and its impact on amyloid β burden in vivo and neuroblastoma cells. Further, we assessed Rubicon levels in human-induced pluripotent stem cells (hiPSCs), derived from early-to-moderate AD and in postmortem samples from severe AD patients. We found increased Rubicon levels in AD-hiPSCs and postmortem samples and a notable Rubicon localization in neurons. In AD transgenic mice lacking Rubicon, we observed intensified amyloid β burden in the hippocampus and decreased Pacer and p62 levels. In APP-expressing neuroblastoma cells, increased APP/amyloid β secretion in the medium was found when Rubicon was absent, which was not observed in cells depleted of Atg5, essential for autophagy, or Rab27a, required for exosome secretion. Our results propose an uncharacterized role of Rubicon on APP/amyloid β homeostasis, in which neuronal Rubicon is a repressor of APP/amyloid β secretion, defining a new way to target AD and other similar diseases therapeutically.
AuthorsSandra Espinoza, Felipe Grunenwald, Wileidy Gomez, Felipe García, Lorena Abarzúa-Catalan, Sebastián Oyarce-Pezoa, Maria Fernanda Hernandez, Bastián I Cortés, Markus Uhrig, Daniela P Ponce, Claudia Durán-Aniotz, Claudio Hetz, Carol D SanMartín, Victor H Cornejo, Fernando Ezquer, Valentina Parra, Maria Isabel Behrens, Patricio A Manque, Diego Rojas-Rivera, René L Vidal, Ute Woehlbier, Melissa Nassif
JournalCells (Cells) Vol. 11 Issue 12 (06 07 2022) ISSN: 2073-4409 [Electronic] Switzerland
PMID35740989 (Publication Type: Journal Article)
Chemical References
  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Autophagy-Related Proteins
  • Intracellular Signaling Peptides and Proteins
  • RUBCN protein, human
Topics
  • Alzheimer Disease (metabolism)
  • Amyloid beta-Peptides (metabolism)
  • Amyloid beta-Protein Precursor (metabolism)
  • Animals
  • Autophagy-Related Proteins (metabolism)
  • Humans
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • Mice
  • Mice, Transgenic
  • Neuroblastoma (metabolism)
  • Neurodegenerative Diseases (metabolism)
  • Neurons (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: